POINT: Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 22, 2023

(marketscreener.com) INDIANAPOLIS, Dec. 18, 2023 /PRNewswire/ -- Eli Lilly and Company today announced the extension of the expiration of the tender offer to acquire all of the issued and outstanding shares of common stock of POINT Biopharma Global Inc. , for a purchase price of $12.50 per share in cash, without interest and less any applicable tax...https://www.marketscreener.com/quote/stock/POINT-BIOPHARMA-GLOBAL-IN-124363438/news/Lilly-Extends-Tender-Offer-to-Acquire-POINT-Biopharma-to-Dec-22-2023-45589228/?utm_medium=RSS&utm_content=20231218